+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Opioid Dependence"

Asia Pacific Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Opioid Use Disorder (OUD) Market Size, Share & Industry Trends Analysis Report By Drug Class (Buprenorphine, Methadone and Naltrexone), By Route of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 92 Pages
  • Asia Pacific
From
Loading Indicator

The Opioid Dependence market is a subset of the Addiction Disorders Drugs market, which includes medications used to treat substance use disorders. Opioid Dependence medications are used to treat individuals with opioid use disorder, a condition characterized by compulsive opioid use despite negative consequences. These medications work by reducing cravings and withdrawal symptoms, and can be used as part of a comprehensive treatment plan. Common medications used to treat opioid dependence include buprenorphine, methadone, and naltrexone. Companies in the Opioid Dependence market include Indivior, Reckitt Benckiser, Orexo, and Braeburn Pharmaceuticals. Show Less Read more